Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd. on March 7, 2024. Post the acquisition, Guiyang Xintian will hold 100% in Shanghai Huilun Biotechnology.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.97 CNY | +1.35% | -1.89% | -3.93% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.93% | 381M | |
+13.32% | 74.45B | |
+11.35% | 9.18B | |
+60.16% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-19.20% | 2.41B | |
+18.63% | 2.39B | |
-27.46% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd.